Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nutriband Inc (NTRB)

Nutriband Inc (NTRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,308
  • Shares Outstanding, K 11,106
  • Annual Sales, $ 2,090 K
  • Annual Income, $ -5,490 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta 1.12
  • Price/Sales 26.15
  • Price/Cash Flow N/A
  • Price/Book 4.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +475,814.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.63 +5.62%
on 11/13/24
6.40 -23.59%
on 10/29/24
-1.44 (-22.75%)
since 10/21/24
3-Month
3.75 +30.41%
on 09/11/24
8.49 -42.40%
on 10/15/24
-0.87 (-15.07%)
since 08/21/24
52-Week
2.22 +120.28%
on 03/15/24
9.60 -49.03%
on 07/24/24
+2.65 (+118.31%)
since 11/21/23

Most Recent Stories

More News
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END

NTRB : 4.80 (-3.61%)
NTRBW : 1.0000 (-44.44%)
LLY : 751.41 (-0.27%)
NVS : 103.87 (+0.76%)
TEVA : 17.07 (+0.23%)
AMRX : 8.38 (-0.36%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

NTRB : 4.80 (-3.61%)
NTRBW : 1.0000 (-44.44%)
LLY : 751.41 (-0.27%)
NVS : 103.87 (+0.76%)
TEVA : 17.07 (+0.23%)
AMRX : 8.38 (-0.36%)
NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY

Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for a patent application covering its Nutriband AVERSA™ abuse deterrent transdermal technology   Nutriband...

NTRB : 4.80 (-3.61%)
NTRBW : 1.0000 (-44.44%)
Nutriband (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) for Flagship Product

Nutriband (NASDAQ: NTRB), a company engaged in the development of prescription transdermal pharmaceutical products, has signed a trademark licensing agreement for the use of Bitrex(R) brand denatonium...

NTRB : 4.80 (-3.61%)
Nutriband (NASDAQ: NTRB) Reports on Share Repurchase Program

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has authorized a share repurchase program to buy back up to $1 million of its common stock. According to the announcement,...

NTRB : 4.80 (-3.61%)
Nutriband (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, is reporting its Q2 2024 financial results for the period ending July 31, 2024. According to the report, the company ended...

WMT : 88.48 (+1.49%)
WBA : 8.30 (+0.73%)
NTRB : 4.80 (-3.61%)
Nutriband (NASDAQ: NTRB) Execs to Participate in July 25 Investor Webinar

Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, is inviting investors to a live webinar. Scheduled for July 25, 2024, at 4:15 p.m. ET, this exclusive...

NTRB : 4.80 (-3.61%)
Nutriband (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”). According to the announcement,...

NTRB : 4.80 (-3.61%)
Nutriband (NASDAQ: NTRB) Shares Update on AVERSA(TM) Fentanyl Product Development Program

Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, today provided an update on its AVERSA(TM) Fentanyl product development program. This comes as the company...

NTRB : 4.80 (-3.61%)
Nutriband (NASDAQ: NTRB) Releases Q1 2024 Quarterly Report

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceuticals and technology, is reporting its first-quarter 2024 revenues. According to the report, the company saw revenues of $408,532 while also...

NTRB : 4.80 (-3.61%)

Business Summary

Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company is engaged in developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. Nutriband...

See More

Key Turning Points

3rd Resistance Point 5.44
2nd Resistance Point 5.27
1st Resistance Point 5.13
Last Price 4.80
1st Support Level 4.82
2nd Support Level 4.65
3rd Support Level 4.51

See More

52-Week High 9.60
Fibonacci 61.8% 6.78
Fibonacci 50% 5.91
Fibonacci 38.2% 5.04
Last Price 4.80
52-Week Low 2.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar